16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO).

Zhengzhou University
Structural basis for inhibition of the fat mass and obesity associated protein (FTO).

University of Oxford
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents.

University of Connecticut
Structural Optimization and Structure-Activity Relationship of 1H-Pyrazole-4-carboxylic Acid Derivatives as DNA 6mA Demethylase ALKBH1 Inhibitors and Their Antigastric Cancer Activity.

Sichuan University
Discovery of Pyrazolo[1,5-

China Pharmaceutical University
Novel 1,8-Naphthalimide Derivatives As Antitumor Agents and Potent Demethylase Inhibitors.

Nanjing Normal University
Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.

University of Chinese Academy of Sciences
Recent developments of small molecules targeting RNA m

China Pharmaceutical University
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets.

University College London
Structure-Based Design of Selective Fat Mass and Obesity Associated Protein (FTO) Inhibitors.

University of Oxford
Rational Design and Optimization of m

University of California San Diego
Identification of Potent and Selective Inhibitors of Fat Mass Obesity-Associated Protein Using a Fragment-Merging Approach.

Kyoto Prefectural University of Medicine
Structure-Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors.

Chinese Academy of Sciences
Discovery of a potent, selective and cell active inhibitor of m

Nankai University
1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS

Mission Therapeutics